Literature DB >> 22468052

Comparison Between Serum hsCRP and LDL Cholesterol for Search of a Better Predictor for Ischemic Heart Disease.

Subinay Datta1, Zahidul Iqbal, K R Prasad.   

Abstract

Acute myocardial Infarction is one of the major causes of morbidity &amp; mortality in world and atherosclerosis is the major cause of ischemic heart disease. In order to determine the better clinical marker of atherosclerosis, we estimated serum low-density lipoprotein (LDL-C) and high sensitivity C-reactive protein (hsCRP). Hundred patients of myocardial infarction and 100 controls irrespective of age and sex were studied for these parameters over a period of 2 years. The statistical analysis showed that the serum hsCRP was significantly raised in myocardial infarction cases than controls (P < 0.01) but LDL-C was not (P > 0.05). We conclude that the serum hsCRP has better predictive value for risk of atherosclerosis.

Entities:  

Keywords:  Atherosclerosis; LDL cholesterol; Myocardial infarction; hsCRP

Year:  2011        PMID: 22468052      PMCID: PMC3107411          DOI: 10.1007/s12291-010-0100-4

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  30 in total

Review 1.  Inflammation as a cardiovascular risk factor.

Authors:  James T Willerson; Paul M Ridker
Journal:  Circulation       Date:  2004-06-01       Impact factor: 29.690

2.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

3.  C-reactive protein (+1444C>T) polymorphism influences CRP response following a moderate inflammatory stimulus.

Authors:  Francesco D'Aiuto; Juan P Casas; Tina Shah; Steve E Humphries; Aroon D Hingorani; Maurizio S Tonetti
Journal:  Atherosclerosis       Date:  2004-12-18       Impact factor: 5.162

Review 4.  Brief review and critical examination of the use of hs-CRP for cardiac risk assessment with the conclusion that it is premature to use this test.

Authors:  Stanley S Levinson
Journal:  Clin Chim Acta       Date:  2005-03-17       Impact factor: 3.786

Review 5.  Novel clinical markers of vascular wall inflammation.

Authors:  G J Blake; P M Ridker
Journal:  Circ Res       Date:  2001-10-26       Impact factor: 17.367

6.  Interferon-gamma and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: relationship with age, sex, and hormone replacement treatment.

Authors:  A Nakagomi; S B Freedman; C L Geczy
Journal:  Circulation       Date:  2000-04-18       Impact factor: 29.690

7.  Low-density lipoprotein subclass patterns and risk of myocardial infarction.

Authors:  M A Austin; J L Breslow; C H Hennekens; J E Buring; W C Willett; R M Krauss
Journal:  JAMA       Date:  1988-10-07       Impact factor: 56.272

8.  hs-CRP and oxidative stress in young CAD patients: A pilot study.

Authors:  Suman B Sharma; Seema Garg; Abhinav Veerwal; Sridhar Dwivedi
Journal:  Indian J Clin Biochem       Date:  2008-12-20

9.  Circulating thrombotic and haemostatic components in patients with coronary artery disease.

Authors:  Kavita K Shalia; V K Shah; M R Mashru; S L Soneji; J B Vasvani; S S Payannavar; A P Walvalkar; R A Mokal; S M Mithbawkar; K V Kudalkar; A Abraham; P K Thakur
Journal:  Indian J Clin Biochem       Date:  2010-02-10

10.  A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis.

Authors:  Subodh Verma; Chao-Hung Wang; Shu-Hong Li; Aaron S Dumont; Paul W M Fedak; Mitesh V Badiwala; Bikramjit Dhillon; Richard D Weisel; Ren-Ke Li; Donald A G Mickle; Duncan J Stewart
Journal:  Circulation       Date:  2002-08-20       Impact factor: 29.690

View more
  3 in total

Review 1.  Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: a need for screening tools to target interventions.

Authors:  Mark D DeBoer
Journal:  Nutrition       Date:  2012-09-28       Impact factor: 4.008

Review 2.  Endothelial dysfunction in neuroprogressive disorders-causes and suggested treatments.

Authors:  Gerwyn Morris; Basant K Puri; Lisa Olive; Andre Carvalho; Michael Berk; Ken Walder; Lise Tuset Gustad; Michael Maes
Journal:  BMC Med       Date:  2020-10-19       Impact factor: 8.775

3.  Correlation between the severity of coronary artery lesions and levels of estrogen, hs-CRP and MMP-9.

Authors:  Changlei Guo; Shaoli Zhang; Junbiao Zhang; Hui Liu; Peicheng Li; Hengdao Liu; Yakun Wang
Journal:  Exp Ther Med       Date:  2014-02-20       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.